Log In
BCIQ
Print this Print this
 

olaratumab (Lartruvo) (IMC-3G3, LY3012207)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionHuman IgG1 mAb targeting platelet derived growth factor receptor A (PDGFRA; PDGFR2; CD140A)
Molecular Target Platelet derived growth factor receptor A (PDGFRA) (PDGFR2) (CD140A)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today